Under Obama Administration, FDA Broadens Consumer Protections
Readers of beauty magazines are familiar with the articles and advertisements that feature physicians touting the “magical results” that come from using various products to correct conditions ranging...
View ArticleFDA Panelist Who Backed Avandia in Hearings is Paid By Glaxo
As a follow-up to my blog post of July 16, 1010, the Wall Street Journal today reports that an FDA panelist who voted to leave Glaxo’s diabetes drug Avandia on the US market with no additional...
View ArticleFDA Tells Glaxo to Halt Enrollment in Avandia Drug Trial
The good news keeps coming for Glaxo, the pharma giant that makes the diabetes drug Avandia. Yesterday the FDA ordered Glaxo to stop patient enrollment in a study that compared Avandia to a competing...
View ArticleJohnson & Johnson’s DePuy Orthopedic Unit Pulls Hip Implants from Market
The hits just keep coming for drug giant J&J who recently issued recalls for some its most popular and profitable products like Children’s Tylenol, and just last week, its Acuvue contact lenses...
View ArticleSignificant Risk of Heart Attack with Avandia – Is the FDA Protecting You?
The Avandia news continues. Just last month, there was a meeting of a joint advisory committee reporting to the Food and Drug Administration (FDA) concerning the potential health risks of the diabetes...
View ArticleFDA to Restrict Access To Avandia
US and European regulators, in a highly unusual coordinated move have determined a course of action concerning Glaxo-Smith Kline’s diabetes drug Avandia, which was shown to be associated with an...
View ArticleCan Yaz, Yasmin, or Ocella Cause Blood Clots?
On May 31, 2011, the FDA announced that it is reviewing two recent articles in the British Medical Journal on the issue of whether the progestin DROSPIRENONE (a component of YAZ, YASMIN, OCELLA and...
View ArticleWill the FDA recommend a Fosamax “Drug Holiday?”
On September 9, 2011, an Advisory Committee of the FDA studying drug safety will meet to conduct a review of bisphosphonates. These drugs include Fosamax, which was approved in 1995 and prescribed for...
View ArticleFDA Cites Serious Concerns about Fosamax
The FDA Advisory Panel which met on September 9, 2011 called for changes in the warnings on Fosamax and other bisphosphonate drugs. The 17-6 vote, after four years of evaluation, may result in the FDA...
View ArticleNew Study Showing Increased Blood Clots in Yaz, Yasmin, and Ocella Users
On September 26, 2011, the FDA issued a notice that it was concerned about birth control pills with drospirenone and certain doses of estrogen causing blood clots. Yaz/Yasmin/Ocella are in this group....
View Article
